NRAS and BRAF mutation frequency in primary oral mucosal melanoma
Open Access
- 11 July 2011
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 26 (4) , 783-787
Abstract
Oral mucosal melanoma (OMM) is a fatal sarcoma of unknown etiology. Histological morphology and genetic events are distinct from those of its cutaneous counterpart. Mutation and up-regulation of c-kit has been identified in OMM which may activate downstream molecules such as RAS and RAF. These molecules are involved in the mitogen-activated protein kinase (MAPK) pathway leading to tremendous cell proliferation and survival. NRAS and BRAF mutation and protein expression have been studied in other melanoma subtypes. The purpose of this study was to determine RAS protein expression and NRAS and BRAF mutation in 18 primary OMM cases using immunohistochemistry and mutation analysis. Results showed that RAS is intensely expressed in both in situ and invasive OMMs. However, NRAS mutation was only observed in 2/15 polymerase chain reaction (PCR) amplified cases both of which were silent mutations. On the other hand, BRAF missense mutations were observed only in 1/15 cases with PCR amplification. NRAS and BRAF mutations were independent from previously reported c-kit mutations. The classical V600E BRAF mutation was not found; instead a novel V600L was observed suggesting that the oncogenic event in OMM is different from that in skin melanoma. The low frequency of NRAS and BRAF mutations indicate that these genes are not common, but probable events in OMM pathogenesis, most likely independent of c-kit mutation.Keywords
This publication has 26 references indexed in Scilit:
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sitesVirchows Archiv, 2009
- Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomasBritish Journal of Cancer, 2008
- Pathological activation of KIT in metastatic tumors of acral and mucosal melanomasInternational Journal of Cancer, 2008
- C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanomaVirchows Archiv, 2007
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- Immunolocalization and distribution patterns of type IV collagen alpha chains in oral mucosal melanomaVirchows Archiv, 2005
- BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organsJournal of Clinical Pathology, 2005
- Absence of BRAF mutations in UV-protected mucosal melanomasJournal of Medical Genetics, 2004
- Determinants of BRAF Mutations in Primary MelanomasJNCI: Journal of the National Cancer Institute, 2003